Cryptococcus: Mycology and Virulence Insights

undefined
 
Cryptococcus: Mycology and Virulence
 
Professor Malcolm D. Richardson
Mycology Reference Centre, Manchester
Manchester University NHS Foundation Trust
 
 
I
n
t
e
n
d
e
d
 
l
e
a
r
n
i
n
g
 
o
u
t
c
o
m
e
s
To be aware of the common species and habitats of 
Cryptococcus
To understand the structure of 
Cryptococcus 
yeasts
To be aware of the different serotypes of 
Cryptococcus
 spp.
To be aware of  the virulence factors of 
Cryptococcus
 spp.
 
Cryptococcus
 
Ubiquitous encapsulated yeasts belonging to the division Basidiomycota.
Over 
70
 species of 
Cryptococcus
 are known, however, 
Cryptococcus neoformans 
and 
C. gattii 
are
the 
two
 main species implicated in nearly all cases of human cryptococcosis.
C. neoformans 
has 
2
 distinct varieties:
C. neoformans var. neoformans
C. neoformans var. grubii
Other species of less clinical significance includes:
C. laurentii, C. adeliensis, C. albidus, etc.
 
Structure
Yeast
: round or oval
4-6mm in diameter
Surrounded by polysaccharide 
capsules
20-30mm thick
“Titan” cells ~90-100 mm
Melanised
Negatively stains with India Ink and nigrosin
Stains with PAS and mucicarmine
 
 
Habitat
 
C. neoformans
Frequently isolated from soil contaminated with pigeon or other bird droppings and NOT in fresh wet
droppings.
The precise link between 
C. neoformans 
and birds to date remains unclear.
Birds do not get infected
.
C. gattii
Isolated from decaying wood in the red gum group of eucalyptus trees, cedar, oak and other native
trees.
C. gattii 
has not been isolated from bird droppings.
 
Serotypes of 
Cryptococcus spp.
 
JN Day :
Practical Neurology
, 2004, 4, 274–285
 
Virulence factors
Major virulence
Polysaccharide capsule formation
Melanin pigment production
Ability to grow well at 37
0
C
Phenotypic switching
Other virulence
Secreted phospholipase B
Urease production
Enzymes associated with
protection against oxidative
stresses
 
Virulence factors
 
Polysaccharide capsule formation
Comprised of glucuronoxylomannan (GXM) and galactoxylomannan (GalXM)
Key roles
Anti-phagocytic
Antibody unresponsiveness
Inhibition of leucocyte migration
Deregulation of cytokine secretion
Interference with antigen presentation
L-selectin & tumor necrosis factor loss
 
Virulence factors
 
Melanin pigment production
Catalyzed by the enzyme 
Phenol oxidase
Key Roles
Antioxidant
Cell wall support and integrity
Interference with T-cell response
Reduction of susceptibility to antifungal agents
Abrogation of antibody mediated phagocytosis
Protection from extreme temperature
 
Virulence factors
 
Phenotypic switching
Occurs during chronic infection
Common in serotype A and D strains of 
C. neoformans
Associated with differential gene expression and capsule changes in virulence
“Titan” cell formation
 
 
Normal sized cell
 
Titan cells
 
Titan cell
 
Summary
 
Cryptococcus 
are ubiquitous encapsulated yeasts.
C. neoformans and C. gatti 
are the two main species implicated in clinical
disease.
Cryptococcus spp. have a number of virulence factors.
C. neoformans var. grubii 
(serotype A) is the most common cause of
disseminated disease in HIV/AIDs patients.
undefined
 
END
Slide Note
Embed
Share

Cryptococcus is a genus of encapsulated yeasts with diverse species, primarily C. neoformans and C. gattii causing human cryptococcosis. Understanding their structure, habitat, serotypes, and virulence factors is crucial for diagnosis and management. Key features include polysaccharide capsule formation, various serotypes linked to different patient groups and environments, and virulence factors such as phospholipase B and melanin pigment production.

  • Cryptococcus
  • Mycology
  • Virulence
  • Yeasts
  • Infectious Disease

Uploaded on Mar 02, 2025 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. Cryptococcus: Mycology and Virulence Professor Malcolm D. Richardson Mycology Reference Centre, Manchester Manchester University NHS Foundation Trust

  2. Intended learning outcomes To be aware of the common species and habitats of Cryptococcus To understand the structure of Cryptococcus yeasts To be aware of the different serotypes of Cryptococcus spp. To be aware of the virulence factors of Cryptococcus spp.

  3. Cryptococcus Ubiquitous encapsulated yeasts belonging to the division Basidiomycota. Over 70 species of Cryptococcus are known, however, Cryptococcus neoformans and C. gattii are the two main species implicated in nearly all cases of human cryptococcosis. C. neoformans has 2 distinct varieties: C. neoformans var. neoformans C. neoformans var. grubii Other species of less clinical significance includes: C. laurentii, C. adeliensis, C. albidus, etc.

  4. Structure Yeast: round or oval 4-6mm in diameter Surrounded by polysaccharide capsules 20-30mm thick Titan cells ~90-100 mm Melanised Negatively stains with India Ink and nigrosin Stains with PAS and mucicarmine

  5. Habitat C. neoformans Frequently isolated from soil contaminated with pigeon or other bird droppings and NOT in fresh wet droppings. The precise link between C. neoformans and birds to date remains unclear. Birds do not get infected. C. gattii Isolated from decaying wood in the red gum group of eucalyptus trees, cedar, oak and other native trees. C. gattii has not been isolated from bird droppings.

  6. Serotypes of Cryptococcus spp. GEOGRAPHICAL DISTRIBUTION ENVIRONMENTAL ASSOCIATION AFFECTED PATIENT GROUPS PATHOGEN SEROTYPE HIV patients (98% of all isolates ) Immunocompromised patients Rarely immunocompetent C. neoformans var grubii Birds, particularly pigeon excreta A Worldwide C. gattii B,C Tropics and subtropics Eucalyptus trees Immunocompetent patients C. neoformans var neoformans Birds, particularly pigeon excreta Immunocompromised patients Rarely immunocompetent D European countries C. neoformans var grubii/var neoformans hybrid Rare clinical isolate Immunocompromised AD Not known Not known JN Day :Practical Neurology, 2004, 4, 274 285

  7. Virulence factors Major virulence Other virulence Polysaccharide capsule formation Secreted phospholipase B Melanin pigment production Urease production Ability to grow well at 370C Enzymes associated with protection against oxidative stresses Phenotypic switching

  8. Virulence factors Polysaccharide capsule formation Comprised of glucuronoxylomannan (GXM) and galactoxylomannan (GalXM) Key roles Anti-phagocytic Antibody unresponsiveness Inhibition of leucocyte migration Deregulation of cytokine secretion Interference with antigen presentation L-selectin & tumor necrosis factor loss

  9. Virulence factors Melanin pigment production Catalyzed by the enzyme Phenol oxidase Key Roles Antioxidant Cell wall support and integrity Interference with T-cell response Reduction of susceptibility to antifungal agents Abrogation of antibody mediated phagocytosis Protection from extreme temperature

  10. Virulence factors Phenotypic switching Occurs during chronic infection Common in serotype A and D strains of C. neoformans Associated with differential gene expression and capsule changes in virulence Titan cells Titan cell formation Normal sized cell Titan cell

  11. Summary Cryptococcus are ubiquitous encapsulated yeasts. C. neoformans and C. gatti are the two main species implicated in clinical disease. Cryptococcus spp. have a number of virulence factors. C. neoformans var. grubii (serotype A) is the most common cause of disseminated disease in HIV/AIDs patients.

  12. END

More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#